
    
      This will be a randomized, open-label, 3-way crossover design study to investigate the effect
      of food on the pharmacokinetics, the pharmacodynamics and safety of ASP1941 after
      administration of ASP1941 in healthy non-elderly adult male subjects. Each subject will
      receive a single dose of ASP1941 "under fasting condition", "before meal" and "after meal".
    
  